We never know what demons other people are fighting, even if we think we see their problems from the outside. Those who ...

Game-changing news: Medicare Part D will cover popular weight loss drugs like Wegovy and Ozempic starting in 2026, with ...

njectable medications like Mounjaro (Tirzepatide) and Wegovy (Semaglutide) have been game changers for many people on a weight loss journey. Both Mounjaro vs Wegovy work on similar pathways to help ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

Struggling with obesity is no walk in the park. It crushes your self-esteem and messes with your body image, not to mention that some people might even develop anxiety and depression. Recent ...

This is precisely why Dr Debra Marcos, chief medic at Weight Medics, is calling on patients to completely overhaul their ...

Novo Nordisk's Wegovy consumption jumped 70% after price cuts, lifting share in November. Eli Lilly's Mounjaro still led anti ...

In November, Mounjaro clocked Rs 108 crore in sales, making it the number 1 brand in the IPM, reflecting sustained momentum ...

Tirzepatide, used in Mounjaro and Zepbound, can produce dramatic weight loss and improvements in blood pressure, cholesterol ...

Dec 12 (Reuters) - The European Medicines ‌Agency's ​committee on Friday ‌recommended extending the use of Eli Lilly's ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.